Experienced in Fractured Spine

Dr. Yessar M. Hussain

Neurology | Neuroradiology
Texas Health Resources
National Neuromonitoring Service
2915 W. Bitters Rd, Ste 201, 
San Antonio, TX 
On Staff At
Offers Telehealth
Experienced in Fractured Spine
Texas Health Resources
National Neuromonitoring Service
2915 W. Bitters Rd, Ste 201, 
San Antonio, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yessar Hussain is a Neurologist and a Neuroradiologist in San Antonio, Texas. Dr. Hussain is rated as an Experienced provider by MediFind in the treatment of Fractured Spine. His top areas of expertise are Cervical Myelopathy, Invertebral Disc Disease, Fractured Spine, and Sciatica.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Baghdad College Of Medicine (2002)
Residency
Suny Upstate Medical University - GME (2011)
Specialties
Neurology
Neuroradiology
Licenses
Electrodiagnostic Medicine in TX
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
Washington University - Neuromuscular Fellowship (2012)
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sendero
  • HMO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

National Neuromonitoring Service
2915 W. Bitters Rd, Ste 201, San Antonio, TX 78248
Call: 210-598-2800

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 6-Month Extension Study Following Protocol VMALS-002-2 (A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis)
A 6-Month Extension Study Following Protocol VMALS-002-2 (A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis)
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

13 Total Publications

Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.
Journal: Annals of medicine
Published: September 20, 2025
View All 13 Publications
Similar Doctors
Advanced in Fractured Spine
Dr. Gregory Boys
Neuroradiology
Advanced in Fractured Spine
Dr. Gregory Boys
Neuroradiology

Methodist Hospital

7700 Floyd Curl Dr, 
San Antonio, TX 
 (77.1 miles away)
210-617-9050
Languages Spoken:
English
See accepted insurances

Gregory Boys is a Neuroradiologist in San Antonio, Texas. Dr. Boys is rated as a Distinguished provider by MediFind in the treatment of Fractured Spine. His top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Stroke, Vertebroplasty, and Bone Graft.

Experienced in Fractured Spine
Dr. Wilson Altmeyer
Neuroradiology
Experienced in Fractured Spine
Dr. Wilson Altmeyer
Neuroradiology

Methodist Hospital

7700 Floyd Curl Dr, 
San Antonio, TX 
 (77.1 miles away)
210-575-4343
Languages Spoken:
English
See accepted insurances

Wilson Altmeyer is a Neuroradiologist in San Antonio, Texas. Dr. Altmeyer is rated as a Distinguished provider by MediFind in the treatment of Fractured Spine. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Vertigo, and Normal Pressure Hydrocephalus.

Experienced in Fractured Spine
Dr. Walter E. Zink
Radiology | Neuroradiology | Pediatric Radiology
Experienced in Fractured Spine
Dr. Walter E. Zink
Radiology | Neuroradiology | Pediatric Radiology

South Texas Radiology Group PA

1905 E State Hwy 97, 
Jourdanton, TX 
 (109.7 miles away)
830-769-3515
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Walter Zink is a Radiologist and a Neuroradiologist in Jourdanton, Texas. Dr. Zink is rated as a Distinguished provider by MediFind in the treatment of Fractured Spine. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Hydrocephalus, Bone Graft, and Vertebroplasty. Dr. Zink is currently accepting new patients.

VIEW MORE FRACTURED SPINE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hussain's expertise for a condition
ConditionClose
      • Advanced
      • Cervical Myelopathy
        Dr. Hussain is
        Advanced
        . Learn about Cervical Myelopathy.
        See more Cervical Myelopathy experts
      • Invertebral Disc Disease
        Dr. Hussain is
        Advanced
        . Learn about Invertebral Disc Disease.
        See more Invertebral Disc Disease experts
      • Experienced
      • Fractured Spine
        Dr. Hussain is
        Experienced
        . Learn about Fractured Spine.
        See more Fractured Spine experts
      • Sacroiliac Joint Disease
        Dr. Hussain is
        Experienced
        . Learn about Sacroiliac Joint Disease.
        See more Sacroiliac Joint Disease experts
      • Sciatica
        Dr. Hussain is
        Experienced
        . Learn about Sciatica.
        See more Sciatica experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.